Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: Evidence for clinical and economic benefit

Journal of Clinical Oncology

Volumn 15, Issue 2, 1997, Pages 451-457

  McQuaker, I G ^a   Hunter, A E ^a   Pacey, S ^a   Haynes, A P ^a   Iqbal, A ^a   Russell, N H ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; ANTIBIOTIC AGENT; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; AUTOTRANSPLANTATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; FEVER; HOSPITAL COST; HOSPITALIZATION; HUMAN; LEUKAPHERESIS; LEUKOCYTE COUNT; LYMPHOMA; MALE; MYELOMA; NEUTROPHIL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STEM CELL TRANSPLANTATION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031017172     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.2.451     Document Type: Article

References (25)

1. Gratwohl A, Hermans J, Baldomero A, et al.: Indications for haemopoietic precursor cell transplants in Europe. Br J Haematol 92:35-43, 1996
2. To LB, Roberts MM, Haylock DN, et al.: Comparison of hematological recovery times and supportive care requirements for autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 9:277-284, 1992
3. Schmitz N, Linen DC, Dreger P, et al.: A randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone marrow transplantation in lymphoma patients. Lancet 347:3563-3567, 1996
4. Morstyn G, Campbell L, Souza LM, et al.: Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1:667-672, 1988
5. Crawford J, Ozer H, Stoller R, et al.: Reduction by granulocyte colony stimulating factor of fever and neutropenia induced by chemotherapy in patients with small cell lung cancer. N Engl J Med 315:164-170, 1991
6. Pettengell R, Gurney H, Radford JA, et al.: Granulocyte colony-stimulating factor to prevent dose limiting neutropenia in non-Hodgkin's lymphoma: A randomized controlled trial. Blood 80:1430-1436, 1992
7. Brandt SJ, Peters WP, Atwater SK, et al.: Effect of recombinant human granulocyte-macrophage colony stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Engl J Med 318:869-876, 1988
8. Sheridan WP, Wolf M, Lusk J, et al.: Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet 2:891-895, 1989
9. Taylor K, Jagannath S, Spitzer G, et al.: Recombinant human granulocyte colony stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease. J Clin Oncol 12:1791-1799, 1989
10. Nemunaitis J, Rabinowe SN, Singer JW, et al.: Recombinant human granulocyte-macrophage colony stimulating factor after autologous bone marrow transplantation for lymphoid cancer. N Engl J Med 324:1773-1778, 1991
11. Carlo-Stella C, Mangoni L, Almici C, et al.: Use of recombinant human granulocyte macrophage colony stimulating factor in patients with lymphoid malignancies treated with unpurged or adjusted dose mafosfamide purged autologous marrow. Blood 80:2412-2418, 1992
12. Gorin NC, Coiffier B, Hayat M, et al.: Recombinant human granulocyte-macrophage colony stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation with unpurged and purged marrow in non-Hodgkin's lymphoma: A double blind, placebo controlled trial. Blood 80:1149-1157, 1992
13. Advani R, Chao NJ, Horning SJ, et al.: Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunt to autologous hemopoietic stem cell transplantation. Ann Intern Med 116:183-189, 1992
14. Klumpp TR, Mangan KF, Goldberg SL, et al.: Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: A prospective, randomized trial. J Clin Oncol 13:1323-1327, 1995
15. Spitzer G, Adkins DR, Spencer V, et al.: Randomized study of growth factors post-peripheral blood stem-cell transplant: Neutrophil recovery is improved with modest clinical benefit. J Clin Oncol 12:661-670, 1994
16. Dunlop DJ, Fitzsimons EJ, McMurray A, et al.: Filgrastim fails to improve haemopoietic reconstitution following myeloablative chemotherapy and peripheral blood stem cell rescue. Br J Cancer 70:943-945, 1994
17. Shimazaki C, Oku N, Uchiyama N, et al.: Effect of granulocyte colony-stimulating factor on hematopoietic recovery after peripheral blood progenitor cell transplantation. Bone Marrow Transplant 13:271-275, 1994
18. Haynes AP, Hunter A, McQuaker G, et al.: Engraftment characteristics of peripheral blood stem cells mobilized with cyclophosphamide and the delayed addition of G-CSF. Bone Marrow Transplant 16:359-363, 1995
19. Linch DC, Milligan DW, Winficld DA, et al.: G-CSF significantly accelerates neutrophil recovery after peripheral blood stem cell transplantation (PBSCT) in lymphoma patients and shortens the time in hospital: Preliminary results of a randomized trial. Blood 86:221, 1995 (suppl; abstr 873)
20. Spitzer G, Adkins D, McIntyre W, et al.: A randomized study showing delayed early platelet recovery after tandem peripheral blood stem cell (PBSC) transplant with growth factors (gf's) post transplant. Blood 86:103, 1995 (suppl; abstr 399)
21. Russell NH, Pacey S: Economic evaluation of peripheral blood stem cell transplantation for lymphoma. Lancet 340:1280, 1992 (letter)
22. Ager S, Scott MA, Mahendra P, et al.: Peripheral blood stem cell transplantation after high-dose therapy in patients with malignant lymphoma: A retrospective comparison with autologous bone marrow transplantation. Bone Marrow Transplant 16:79-83, 1995
23. Brodsky RA, Bedi A, Jones RJ: Are growth factors leukemogenic? Leukemia 10:175-177, 1996
24. Decoster G, Rich W, Brown S: Safety profile of filgrastim (r-metHuG-CSF). New York, NY, Marcel Dekker, 1994
25. Dale D, Bonilla MA, Davis MW, et al.: A randomized controlled phase-III trial of recombinant human granulocyte-colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood 81:2496-2502, 1993